BSE has revised the price band for 35 scrips effective December 02, 2025, with bands ranging from 2% to 20% based on surveillance measures.
Impact
Medium
Severity
Medium
Justification
Price band revisions affect trading flexibility for 35 securities, with tighter bands indicating heightened surveillance but limited to smaller/mid-cap stocks with potentially lower trading volumes.
BSE has revised price bands for 35 scrips ranging from 2% to 20%, effective from December 02, 2025. The changes affect various securities across different sectors including textiles, pharmaceuticals, and financial services.
Impact
Medium
Severity
Medium
Justification
Affects 35 securities with revised price bands indicating increased surveillance measures. Most securities moved to 5% band with some having tighter 2% bands and others loosened to 10-20%, suggesting varied risk profiles. Traders need to adjust strategies for these securities.
BSE announces demat auction settlement for 89 securities across multiple companies with specified quantities to be auctioned on November 28, 2025.
Impact
Medium
Severity
Medium
Justification
Routine demat auction affecting 89 securities with varying quantities. This is a standard settlement process for failed delivery obligations, with medium impact as it affects multiple scrips but is a regular market operation.
Certificate of incorporation issued by Ministry of Corporate Affairs confirming the name change of SMS Lifesciences India Limited to Haleos Labs Limited effective August 20, 2025.
Impact
Low
Severity
Low
Justification
Administrative name change with no impact on company operations, rights, or liabilities. Only affects branding and corporate identity.
BSE demat auction settlement no. 753 listing securities available for auction across various scrips.
Impact
Low
Severity
Low
Justification
Routine demat auction settlement listing securities available for auction. Affects only parties with delivery obligations in the listed scrips. No market-wide regulatory changes or compliance requirements.
BSE demat auction settlement no. 753 listing securities available for auction to cover shortages in demat delivery obligations.
Impact
Medium
Severity
Medium
Justification
Routine demat auction for settlement 753 affecting multiple securities. Medium impact for specific securities with delivery shortages but low overall market importance as this is a standard settlement mechanism.
BSE demat auction settlement listing securities across multiple scrips for auction on November 12, 2025.
Impact
Medium
Severity
Medium
Justification
Demat auction affects multiple securities and their shareholders who failed to deliver shares, requiring auction settlement. Moderate market impact limited to specific scrips and quantities listed.
SMS Pharmaceuticals Ltd lists 50 lakh new equity shares issued to promoters on preferential basis pursuant to warrant conversion, with lock-in period until October 2027.
Impact
Low
Severity
Low
Justification
Routine equity listing from warrant conversion with standard lock-in; limited immediate market impact as shares issued to promoters